iBio Current Cash

iBio (IBIO) currently reports a current cash of $48M as of March 2026. That compares with $5M in the prior-year period — up 860.5% year over year. Use the charts on this page to explore iBio's current cash history and peer comparisons.

iBio's current cash increased from $5M to $48M — a 860.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

iBio reported $48M in current cash as of March 2026. That compares with $5M in the prior-year period — up 860.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $48M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for iBio, and consider following IBIO for alerts when major investors trade the stock.

iBio is classified in the Healthcare sector. On current cash, it currently shows $48M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IBIO with unrelated industries.